Literature DB >> 28717720

First of All, I Feel Very Loved: Humanism and Cancer Care in South India.

Christopher M Booth1.   

Abstract

Entities:  

Year:  2016        PMID: 28717720      PMCID: PMC5493258          DOI: 10.1200/JGO.2016.006296

Source DB:  PubMed          Journal:  J Glob Oncol        ISSN: 2378-9506


× No keyword cloud information.
As a senior medical resident I made a last-minute career detour into medical oncology after spending just 2 days in the cancer clinic. What drew me strongly to oncology were the unique and very real human interactions oncologists have with their patients. The opportunity to be present and bear witness to the courage of patients and families who face cancer is a true privilege. We repeatedly see patients let go of the peripheral things in life that do not matter and focus on things that matter most. Being part of this experience can be uplifting and inspiring. I knew that the relationship between oncologist and patient was something that I would treasure throughout my career. Humanistic medicine is a contemporary movement that embraces the fundamental elements of medicine, including integrity, clinical excellence, compassion, altruism, respect, empathy, and service.[1] Recent literature shows that almost half of medical oncologists experience burnout and that we are at risk of losing the ideals that bring us to medicine in the first place.[2] In this commentary, I describe how a recent sabbatical in South India broadened my perspective on what matters most in the practice of medicine. As a university-based medical oncologist and health services researcher, I spend my time caring for patients, undertaking clinical research, and teaching house staff. In 2014, I was invited to participate in the World Oncology Forum (WOF).[3] This event brings together a diverse group of individuals from across the globe who have expertise in clinical care, research, education, advocacy, and health policy. As a health services researcher with an interest in optimizing the societal benefit of new cancer therapies,[4] the WOF theme, “Treat the Treatable,” was highly relevant. This meeting allowed me to present my own work and interact with like-minded individuals from high-income countries and low- to middle-income countries (LMICs). This led to an opportunity to spend a 3-month sabbatical in South India to build a collaborative program in cancer health services research. In late 2015, my wife and I packed up our four young children and moved to Kerala, where I had the privilege of working at the Regional Cancer Centre (RCC) in Trivandrum. Cancer is now recognized as a major threat to public health in LMICs.[5] Access to cancer care demonstrates a striking paradox, in which 5% of global resources for cancer are spent in LMICs, where 64% of global deaths as a result of cancer occur.[5,6] More than one million new occurrences of cancer are diagnosed annually in India, which has a population of 1.2 billion.[7] The high cancer mortality rate (68% annual incidence) in India likely reflects the large proportion of patients who present with advanced disease and the limited access to cancer care in some parts of India.[8] Kerala (population, 33 million) is located on the southwest coast of India and has the highest literacy rate, greatest life expectancy, and lowest infant mortality rate in India.[9,10] Kerala is widely recognized as a leader among LMICs in the delivery of cancer care.[11-15] The RCC in Trivandrum is the oldest and largest comprehensive cancer treatment center in Kerala. The RCC is a government institution that provides highly subsidized or free care to most of its 16,000 new patients seen each year. The most striking observations from my experience were (1) the overwhelming number of sick patients, (2) the advanced stages of disease, (3) the compassion and dedication of Indian oncologists, and (4) the remarkable similarity in treatment delivered to patients at RCC and patients in Canada. In Canada and the United States, a busy medical oncologist might see 25 patients in a full day of clinic. Unless we are on call, we do not see patients on the weekend. My colleagues at the RCC see patients 6 days per week, and it is not uncommon for physicians to see up to 80 patients per day. These high clinic volumes are not surprising when one considers that RCC has almost four times the patient volume of my own center yet has two thirds of the clinical work force. With this remarkably high patient volume, the most notable difference in care was the lack of time to have important conversations about prognosis, treatment options, and goals of care. My colleagues at the RCC recognized this limitation and addressed these important issues to the best of their ability in the midst of an overwhelming volume of sick patients. Although I could not follow many conversations that took place in Malayalam, the facial expressions and body language of patients and families in India are the same as what I see in my clinic at home in Canada. I saw evidence of fear, worry, and pain, but I also saw expressions of hope, optimism, and evidence of a deep caring for the sick. The dedication, skill, and compassion of my Indian colleagues cannot be overstated. Many of them could work in the private sector in India or elsewhere in the world, where they would have much higher income for comparatively less work. However, I was struck by their senses of altruism and individual responsibility to improve the lives of patients with cancer in India. These senses of duty, purpose, and altruism made it especially difficult to receive weekly e-mail bulletins from my province’s physician organization in Canada that was involved in a public conflict with the government over physician remuneration. I was amazed that, despite the grueling workload on the other 6 days per week, I was repeatedly invited to large community events held on Sunday (the only day away from work), at which a team of physicians and community-based volunteers offered cancer awareness and screening camps to the most destitute communities. At one of these events, I was treated as a guest of honor and shared the stage with the mayor of Trivandrum. My children quickly learned that speeches at these events can go on for some time and are occasionally punctuated by explosions of loud firecrackers. When the time came for me to speak, I offered greetings “from the people of Canada in the Great White North” and thanked the community for so graciously welcoming my family. With their bright blond hair and blue eyes, my children were the subject of many photographs and became instant celebrities in Kerala. The incredible efficiency of the RCC was made possible by the strong work ethic of my Indian colleagues and by the patients’ families, who play essential roles in the coordination and delivery of care. Each patient was accompanied by at least one family member, who took responsibility for bringing test results and consultant reports to clinic, booking future appointments, and even hand-delivering chemotherapy orders to the treatment unit. The importance of family support permeated all elements of cancer care that I witnessed in Kerala. Outside of the RCC, I had the privilege of working with Pallium India, a globally recognized non-governmental organization that provides clinical care, educates health professionals, and serves as a national advocate for palliative care. During home visits with Pallium India, I witnessed firsthand how a community-based network of volunteers can provide comfort in the face of scarce resources. Traveling by van through the narrow streets of Trivandrum, I made house calls with a physician, nurse, and social worker. The breadth of medical, emotional, and psychosocial problems to which these teams tend is remarkable. I witnessed untold care and compassion delivered to a young boy dying at home with painful bone metastases. I witnessed the joy that the team’s visit brought to a socially isolated man with Parkinson disease. He remained a gracious host to us as visiting Canadians even after my resident forgot to latch the gate and his chickens almost escaped! I also met an impoverished mother and father who provided remarkable care to their cognitively impaired daughter in their clean but simple home with dirt floors. Although unable to afford diapers (which cost $2 per day), these parents managed to avoid pressure sores in their incontinent daughter by changing soiled bedsheets and washing them by hand several times per day. The compassion of the physicians and staff at Pallium India and the critical role of family in the provision of care for the terminally ill represent the epitome of humanistic medicine. My family and I have returned to Canada, but we remain profoundly affected by our time in Kerala. Our children have a newfound appreciation of the many things we have in Canada for which we should be grateful. They also have gained insight into poverty and what life is like for people who live elsewhere in the world. I also have returned to work with a renewed sense of purpose. The work ethic, skill, and dedication of my colleagues in India was humbling and has helped me focus on how I can use my career as an oncologist and health services researcher in a high-income country to achieve the greatest good for patients worldwide. My sabbatical has also reaffirmed the role of humanism in my clinical work. Even when we cannot cure the disease, we can still provide comfort, care, and compassion to our patients. The most striking reminder of this came during a home visit of an elderly man who was dying with pancreatic cancer. I asked the physician with whom I was working to ask the patient what he most valued about the visits from the palliative care team. His response captured the essence of humanism in cancer care; translated from Malayalam, he stated simply, “First of all, I feel very loved.”
  11 in total

1.  Translating new medical therapies into societal benefit: the role of population-based outcome studies.

Authors:  Christopher M Booth; William J Mackillop
Journal:  JAMA       Date:  2008-11-12       Impact factor: 56.272

Review 2.  Cancer survival: global surveillance will stimulate health policy and improve equity.

Authors:  Michel P Coleman
Journal:  Lancet       Date:  2013-12-16       Impact factor: 79.321

Review 3.  Expansion of cancer care and control in countries of low and middle income: a call to action.

Authors:  Paul Farmer; Julio Frenk; Felicia M Knaul; Lawrence N Shulman; George Alleyne; Lance Armstrong; Rifat Atun; Douglas Blayney; Lincoln Chen; Richard Feachem; Mary Gospodarowicz; Julie Gralow; Sanjay Gupta; Ana Langer; Julian Lob-Levyt; Claire Neal; Anthony Mbewu; Dina Mired; Peter Piot; K Srinath Reddy; Jeffrey D Sachs; Mahmoud Sarhan; John R Seffrin
Journal:  Lancet       Date:  2010-08-13       Impact factor: 79.321

4.  Cancer survival in Africa, Asia, and Central America: a population-based study.

Authors:  Rengaswamy Sankaranarayanan; Rajaraman Swaminathan; Hermann Brenner; Kexin Chen; Kee Seng Chia; Jian Guo Chen; Stephen C K Law; Yoon-Ok Ahn; Yong Bing Xiang; Balakrishna B Yeole; Hai Rim Shin; Viswanathan Shanta; Ze Hong Woo; Nimit Martin; Yupa Sumitsawan; Hutcha Sriplung; Adolfo Ortiz Barboza; Sultan Eser; Bhagwan M Nene; Krittika Suwanrungruang; Padmavathiamma Jayalekshmi; Rajesh Dikshit; Henry Wabinga; Divina B Esteban; Adriano Laudico; Yasmin Bhurgri; Ebrima Bah; Nasser Al-Hamdan
Journal:  Lancet Oncol       Date:  2009-12-10       Impact factor: 41.316

Review 5.  Provision of Palliative Care in Low- and Middle-Income Countries: Overcoming Obstacles for Effective Treatment Delivery.

Authors:  Breffni Hannon; Camilla Zimmermann; Felicia M Knaul; Richard A Powell; Faith N Mwangi-Powell; Gary Rodin
Journal:  J Clin Oncol       Date:  2015-11-17       Impact factor: 44.544

6.  Burnout and career satisfaction among US oncologists.

Authors:  Tait D Shanafelt; William J Gradishar; Michael Kosty; Daniel Satele; Helen Chew; Leora Horn; Ben Clark; Amy E Hanley; Quyen Chu; John Pippen; Jeff Sloan; Marilyn Raymond
Journal:  J Clin Oncol       Date:  2014-01-27       Impact factor: 44.544

7.  The growing burden of cancer in India: epidemiology and social context.

Authors:  Mohandas K Mallath; David G Taylor; Rajendra A Badwe; Goura K Rath; V Shanta; C S Pramesh; Raghunadharao Digumarti; Paul Sebastian; Bibhuti B Borthakur; Ashok Kalwar; Sanjay Kapoor; Shaleen Kumar; Jennifer L Gill; Moni A Kuriakose; Hemant Malhotra; Suresh C Sharma; Shilin Shukla; Lokesh Viswanath; Raju T Chacko; Jeremy L Pautu; Kenipakapatnam S Reddy; Kailash S Sharma; Arnie D Purushotham; Richard Sullivan
Journal:  Lancet Oncol       Date:  2014-04-11       Impact factor: 41.316

8.  Cancer research in India: national priorities, global results.

Authors:  Richard Sullivan; Rajendra A Badwe; Goura K Rath; C S Pramesh; V Shanta; Raghunadharao Digumarti; Anil D'Cruz; Suresh C Sharma; Lokesh Viswanath; Arun Shet; Manavalan Vijayakumar; Grant Lewison; Mammen Chandy; Priyadarshini Kulkarni; M R Bardia; Shaleen Kumar; Rajiv Sarin; Paul Sebastian; Preet K Dhillon; Preetha Rajaraman; Edward L Trimble; Ajay Aggarwal; D K Vijaykumar; Arnie D Purushotham
Journal:  Lancet Oncol       Date:  2014-04-11       Impact factor: 41.316

9.  Delivery of affordable and equitable cancer care in India.

Authors:  C S Pramesh; Rajendra A Badwe; Bibhuti B Borthakur; Madhu Chandra; Elluswami Hemanth Raj; T Kannan; Ashok Kalwar; Sanjay Kapoor; Hemant Malhotra; Sukdev Nayak; Goura K Rath; T G Sagar; Paul Sebastian; Rajiv Sarin; V Shanta; Suresh C Sharma; Shilin Shukla; Manavalan Vijayakumar; D K Vijaykumar; Ajay Aggarwal; Arnie Purushotham; Richard Sullivan
Journal:  Lancet Oncol       Date:  2014-04-11       Impact factor: 41.316

10.  Challenges to effective cancer control in China, India, and Russia.

Authors:  Paul E Goss; Kathrin Strasser-Weippl; Brittany L Lee-Bychkovsky; Lei Fan; Junjie Li; Yanin Chavarri-Guerra; Pedro E R Liedke; C S Pramesh; Tanja Badovinac-Crnjevic; Yuri Sheikine; Zhu Chen; You-lin Qiao; Zhiming Shao; Yi-Long Wu; Daiming Fan; Louis W C Chow; Jun Wang; Qiong Zhang; Shiying Yu; Gordon Shen; Jie He; Arnie Purushotham; Richard Sullivan; Rajendra Badwe; Shripad D Banavali; Reena Nair; Lalit Kumar; Purvish Parikh; Somasundarum Subramanian; Pankaj Chaturvedi; Subramania Iyer; Surendra Srinivas Shastri; Raghunadhrao Digumarti; Enrique Soto-Perez-de-Celis; Dauren Adilbay; Vladimir Semiglazov; Sergey Orlov; Dilyara Kaidarova; Ilya Tsimafeyeu; Sergei Tatishchev; Kirill D Danishevskiy; Marc Hurlbert; Caroline Vail; Jessica St Louis; Arlene Chan
Journal:  Lancet Oncol       Date:  2014-04       Impact factor: 41.316

View more
  1 in total

1.  Delivery of Cancer Care in India and Canada: Opportunities for Bidirectional Learning.

Authors:  Sunu Cyriac; Christopher M Booth
Journal:  J Glob Oncol       Date:  2019-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.